Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.

Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)



Recent publications

Publication

The UK Football Governance Bill: Impact on ownership

The UK Football Governance Bill (the Bill), reintroduced by the current Labour government in 2024, marks a significant shift in the regulation of English football.

United Kingdom | July 03, 2025

Financial services and regulation
Merger Control Regime

Publication

Australia’s new mandatory merger control regime

Mergers or acquisitions that meet certain turnover thresholds will shortly be required to be notified to the ACCC.

Australia | July 03, 2025

Consumer markets
Bright Buildings

Publication

Beyond the ballot: A look at proxy season 2025 shareholder proposals

Even when shareholder proposals fall short at the polls, their influence can resonate beyond the vote count and plant the seed for potential shifts in shareholder engagement themes.

Canada | July 3, 2025

Corporate, M&A and securities
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now